Your basket is currently empty!
Nivolumab+Sitravatinib Combo Impresses in RCC
Combining a broad-spectrum tyrosine kinase inhibitor (TKI) with an immune checkpoint inhibitor resulted in a high ...
News Archive
Sitravatinib
Our work depends on donations from generous people so that we can support those affected by kidney cancer.
Would you like to support our work through a donation?
